Daniel D Holsworth
Structure and fragment based drug design; Drug discovery and development technologies; Organic synthesis; Pharmacokinetic property optimization; Nanomedicine and drug delivery technologies.
Holsworth is CEO of Stem Next, LLC, a San Diego, CA-based drug discovery company focused on cosmeceutical and dermatology therapeutics. He is a drug discovery expert and entrepreneur with over 24 years of research experience and has served in multiple senior level positions in the biotech and Pharma industry, including Amylin Pharmaceuticals and Pfizer Global Research & Development. He has also co-founded three drug discovery companies: P&H Therapeutics, Inc.; ODIN Therapeutics A/S; and Stem Next, LLC. His research projects over the years have focused on a variety of therapeutic areas-Oncology: cardiovascular, metabolic, and inflammatory and inflammatory diseases; central nervous system (CNS) gene therapy and most recently, dermatology and have culminated in over half a dozen clinical candidates. He earned his doctorate in synthetic organic chemistry from Wayne State University in Detroit, Michigan and was a Post Doctoral Fellow in Medicinal Chemistry at Parke-Davis Pharmaceuticals in Ann Arbor, Michigan.
Kaplan University Online
Advances of innovation in society and the hindrances to innovation; The focus is on Patent Policy.
Kent Acheson, D.B.A., MBA (Adjunct Professor) Kent Acheson is the VP of Finance and Operations for Acheson Consulting, LLC. He has managed Acheson Consulting since 2003 and performed all financial management functions, including P&L, budgeting, forecasting, all cash management, taxes, and analyses, as well as, reports to management, including the financial statements and revenue/expense analysis. He received his MBA in 2006 and his D.B.A. in 2012 from the University of Phoenix. Currently, he is adjunct professor teaching graduate healthcare administration finance, the lead faculty, and SME Finance for Healthcare Administration with Kaplan University Online. He is adjunct with Ohio Christian University Online teaching graduate Adult Education accounting, finance, and healthcare management. Also, he is adjunct with JFKU Online teaching undergraduate accounting. He has over 20 years experience with team collaboration, team building and leadership. He published a research paper titled A Study of the Need to Change United States Patent Policy at ProQuest (2012) at the following website address– http://gradworks.umi.com/3528760.pdf, which focused on the Pharmaceutical and Software Industries. His research interests are in the advances of innovation in society and the hindrances to innovation. The focus is on Patent Policy. He has also published research titled Patent Trolls Among Us at bepress (2013) at the following website address- http://works.bepress.com/kent_acheson/2. He has been teaching Accounting/Finance since 2008; and, is currently a member and manuscript reviewer for Healthcare Financial Management Association (HFMA) publication hfm.
Syed A A Rizvi
Nova Southeastern University
Micro and Nano-Technology for Drug Delivery; Controlled Release Formulations; Solid State Chemistry of the Drugs; Surface Chemistry; Analytical Chemistry; Soft Material Chemistry; Forensic Chemistry; Organic Chemistry; Natural Product Chemistry; Vaccinology and Immunology.
Dr. Rizvi pursued an M.S and Ph.D combined degree program at the Center for Biotechnology and Drug Design, Department of Chemistry, Georgia State University (GSU), Atlanta, GA. While working at GSU, He was trained in the areas of Analytical Chemistry, Separation Sciences, Bioanalysis, Surfactant Chemistry, Chiral Separations of the Drugs, Trace Level Analysis (Forensic Chemistry) of Drugs in human body fluids (led to a US and International patent). Right after finishing M.S and Ph.D at the GSU, he pursued another Ph.D (under Prof. Martin J. D Souza) at the College of Pharmacy and Health Sciences, Department of the Pharmaceutical Sciences, Mercer University (MU), Atlanta, GA in collaboration with Dr. Scott L Childs (founder and chief Scientific officer, Renovo Research, LLC). At Mercer, he was trained in the areas of Solid Dosage Formulations (direct compressed tablets), Controlled Release Formulations, Nanoparticulate System for Non-Invasive real time In Vivo Imaging, Cell-Lipid interaction Studies. At Renovo, he was trained in the area of Solid State Chemistry of the Drugs, e.g., Polymorphism and Cocrystallization . He also pursued postdoctoral research in the laboratory of Dr. Fredric M. Menger (Charles Howard Candler Professor) at the Sanford S. Atwood Chemistry Center, Emory University, where he polished his skills in Organic Synthesis, Soft Material Chemistry, Surface and Interfacial Sciences, Gene Transfection Studies using Gemini Surfactants, State of the art, Langmuir-Adam Balance Studies. Moreover, he conducted research as a visiting scientist in the area of pharmaceutical ionic liquids, in the laboratory of Dr. Robin D. Rogers (Robert Ramsay Chair of Chemistry, Distinguished Research Professor and Director, Center for Green Manufacturing) at the Department of Chemistry, The University of Alabama. At the University of Alabama, Dr. Rizvi, Synthesized new salts and ionic liquids of the pharmaceutical compounds with improved solubility and permeability and with prophylactic counter ¬ions for reduction in drug induced toxicity. Characterized the newly synthesized ionic liquid with NMR, IR, TGA, DSC, X-ray and Karl Fischer titration and In vivo studies (transdermal formulations) of various ionic liquids. Recently, he finished course of studies leading to Master of Business Administration (MBA) degree with specialization in Pharmaceutical Marketing and Management from Aspen University and a certificate in Executive Leadership from Johnson Graduate School of Management, eCornell Professional Development Programs, Cornell University. He has Published 103 peer reviewed articles that including, 51 journal papers, 48 oral and poster presentation abstracts, 2 book chapters, 1 text book, and 1 US patent (US8168440). His publications include two most highly rated articles, two cover articles and one figure from his paper was included in the textbook Quantitative Chemical Analysis by Daniel C. Harris (7th Edition, p 616, W. H. Freeman, 2006, ISBN-10: 0716770415). He also presents his work through posters and oral presentations in national and international conferences. He serves as editor-in-chief, associate editor, executive editor and editorial board member for 35 different journals (various capacities) and review manuscripts and books for 76 well known scientific publications (journals and books). He enjoys teaching and engaging students in thought process and practice Martial Arts.
University of Barcelona
Peptide synthesis (new reactions; building blocks; coupling reagents; solid phase supports; protecting groups and linkers; Combinatorial chemistry methodologies; Synthesis of peptides; Small molecules with therapeutic activities; Furthermore, his group is also involved in developing new systems for drug delivery and strategies for diagnostics.
Fernando Albericiois Professor at the University of Barcelona, Group Leader at the Institute for Research in Biomedicine-Barcelona, and Research Professor at the University of KwaZulu-Natal in Durban, South Africa. His major research interests cover practically all aspects of peptide synthesis (new reactions, building blocks, coupling reagents, solid phase supports, protecting groups, and linkers) and combinatorial chemistry methodologies, as well as synthesis of peptides and small molecules with therapeutic activities. Furthermore, his group is also involved in developing new systems for drug delivery and strategies for diagnostics as well. He has published over 750 papers, filled more than 55 patents, and has co-authored four books. He has also edited several scientific journal and acted in the editorial board of several others. Recently, he has been honored with a Doctorate Honoris Causa by the Universidad de Buenos Aires (Argentina), Vincent du Vigneaud by the American Peptide Society, A-rating by the National Research Foundation (South Africa), the Research Medal of the Royal Society of Chemistry (Spain), isas a Member of the European Academy of Sciences and Arts, and Invited Professor at the University de la Habana (Cuba).
Organic and organometallic chemistry; Asymmetric catalysis; organocatalysis; reaction mechanisms; stereochemistry; and synthesis of functional molecules and molecular probes.
Design; Synthesis and evaluation of novel mitotic kinase inhibitors; Specifically Aurora kinase A to be used alone or in combination with existing anticancer agents. Design; Synthesis and evaluation of dual inhibitors of HIV integrase and ribonuclease H.
Sonali Kurup, Ph.D. graduated from Mumbai University, India in 2002 with a pharmacy degree. She then went on to receive a Ph.D. in medicinal chemistry (2009) from Duquesne University, USA. After postdoctoral research at University of Michigan, USA, Dr. Kurup joined the newly established College of Pharmacy at Roosevelt University, USA in 2011 as Assistant Professor of Medicinal Chemistry. Her research interests include the design, synthesis and evaluation of novel anticancer and antiretroviral agents.
University of Cagliari
Synthesis and structure / activity relationship studies of opioid peptides and pseudopeptides derived from the Dmt-Tic pharmacophore (2,6-dimethyl-L-tyrosine - 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid); Non-peptide prokineticin receptor antagonists; Synthesis and structure / activity relationship studies related to flavonoids.
Gianfranco Balboni was born in Portomaggiore (Ferrara), Italy, in 1956. He received his degrees in Medicinal Chemistry in 1980 and in Pharmacy in 1981, both from the University of Ferrara. He received his PhD in Pharmaceutical Sciences from the University of Ferrara in 1986. In 1986-1998, he was Assistant Professor at the same University. In 1998, he moved to the University of Cagliari as Associate Professor of Medicinal Chemistry. He is author or co-author of about 140 articles and 3 patents. He is the author or co-author of about 140 papers on national and international journals.
Kamal Mohamed Dawood
Kamal M Dawood graduated from Cairo University, Egypt in 1987 then carried out his MSc and PhD studies under the supervision of Professor Ahmad Farag, Cairo University and received his PhD in 1995. In 1997 he was awarded the UNESCO Fellowship for one year and in 1999 he was awarded the JSPS (Japan Society for Promotion of Science) Fellowship for two years and worked in both periods with Professor T. Fuchigami at Tokyo Institute of Technology (TIT) in the field of ‘Electrochemical Partial Fluorination of Heterocyclic Compounds’. In addition, he was awarded the Alexander von Humboldt Fellowship at Hanover University in 2004-2005 with Prof. A. Kirschning (in the field of polymer supported palladium catalysed cross coupling reactions) and in 2007 and 2008 with Prof. Peter Metz at TU-Dresden (in the field of total synthesis of natural products). In 2002 he promoted to Associate Professor and in May 2007 he was appointed as Professor of Organic chemistry, Faculty of Science, Cairo University. In 2002 he received the Cairo University Award in Chemistry and in 2007 he received the State-Award in Chemistry. In 2012 he received the Cairo University Award for Academic Excellence. He published about 113 scientific papers and reviews in distinguished international journals. There are more than 1600 citations of his work from 1993 until 2016 (h-index 22).
Waleed Adbelhakeem Bayoumi
Drug design; Organic synthesis; Heterocyclic Chemistry; Spectral Characterization.
Waleed A. Bayoumi, Ph.D. In 1995, He graduated from Faculty of Pharmacy, Mansoura University, Egypt. He obtained his M.Sc. in Pharmaceutical Organic Chemistry “Synthesis, characterization, and pharmacological screening of novel mesoionic compounds 2001” and Ph.D. in Pharmaceutical Organic Chemistry “Synthesis and structure elucidation of certain new phthalazines of potential anti-inflammatory activity 2007” from Faculty of Pharmacy, Mansoura University. He teaches the courses of Pharmaceutical Organic Chemistry in several Universities. He also has interests in the fields of e-learning and quality assurance in education.
Ibrahim Abdel-Karim Ahmed Abdel-Rahman
University of Sharjah
Synthesie of new organic compounds as corrosion inhibitors- Using plant extract as green chemistry corrosion inhibitors.
Ibrahim Abdel-Rahman was born in Beddya (Nablus), Palestine in 1958. He is a lecturer at University of Sharjah since 2000. He was a lecturer atthe Applied Science University (Jordan) (1994-2000). He was the head of chemistry Lab for quality control at the Arab Center for Pharmaceuticals and Chemicals Industries (Jordan) during (1991-1994). He was a rresearchassociate at the Kuwait Institute for Scientific Research (Kuwait) during (1984-1990). He honored Kuwait Scholarship for Graduate Studies (1982-1984), Kuwait. Recipient of Best Research Paper Award in the field of basic and applied science for the paper entitled “Electrochemical Studies of the Effect of 4-Hydroxy-4-Stilbazole on Corrosion Inhibition of Mild Steel in HCl Solution” at the 4th Annual Scientific Research Forum held during 7– 8May 2008, and organized by College of Graduate Studies & Research, University of Sharjah, Sharjah (UAE). Recipient of Best Research Paper Award in the field of basic and applied science for the paper entitled "Inhibition of Carbon Steel Corrosion by 4-vinylbenzyl triphenylphosphonium chloride in HCl Solution" at the 5th Annual Scientific Research Forum held on 29April 2009, and organized by College of Graduate Studies & Research, University of Sharjah, Sharjah (UAE). He got acknowledgement from the dean of the college of science for the efforts that were done in organizing “The International Chemistry Olympiad” which held at University of Sharjah, 22 March 2010, (UAE). He got acknowledgement from the dean of the college of science for the efforts that were done in organizing “The Second Sharjah Sciences Festival” which held at University of Sharjah, 11-12 May 2011, (UAE). He honored as an outstanding faculty member in the chemistry department during the final ceremony of the Faculty of Science which was held at University of Sharjah on Thursday, 2 June, 2011. He got acknowledgement from the dean of the college of science for the efforts that were done in organizing “The Third Sharjah Sciences Festival” which held at University of Sharjah, 5-6 February 2014, (UAE).
Mohammad Emad Azab Ali El-Fakharany
Ain Shams University
Focused on the syntheses and reactions of wide variety of Heterocyclic Compounds (thienopyrimidines, pyridones, chromanones, coumarins, benzoxazinones , oxazoles , isoxazoles, pyrazoles).
Mohammad Azab Was born in 14-12-1963, Cairo, Egypt. He Received his high school education in El-Ahram high school from 1978-1981. He Received his B.Sc. from Ain Shams University (chemistry major) in 1985 with distinction with class honors. He then he got his M. Sc in organic chemistry in 1990. He got his Ph.D. through a channel system with UCONN (Connecticut State University) USA in 1997. He became assistant professor of organic chemistry at Faculty of Science, Ain Shams University from July 1997 to October 2008. He became Associate professor of organic chemistry at Faculty of Science, Ain Shams University from October 2008 up till now. He got a post doctoral position at University of Regina, Saskatchewan, Canada, 2000. He is interested in the field of heterocyclic chemistry (Synthesis such as pyridones, pyrimidines, thienopyrimidines, benzoxazinones, quinazolinones, phthazinones) and studying their biological activities such as Anticancer, antimicrobial, anti-inflammatory and analgesic. He is responsible for the graduation research projects in Faculty of Science, Ain Shams University. He went into a septic leave to teach in the Libyan Universities from 2003-20013. He published about thirty papers in the field of heterocyclic chemistry, in an international journal. He supervised five M.Sc. thesises and five Ph.D. thesises. He has thirty years of experience in teaching practical and theoretical organic chemistry courses such as amino acids, lipids, proteins, steroids, alkaloids, vitamins, heterocyclic chemistry and Spectroscopy. He has been awarded the international publication prize from Ain Shams University, twice (2010 and 2012). Address: Chemistry department, Faculty of Science, Ain Shams University, Abbassia, Cairo 11556, Egypt.
Shanghai Institute of Materia Medica
Design and synthesis of novel small molecules as structural and functional probes for the diagnosis and treatment of brain disorders and cancer by using the state-of-art medicinal chemistry strategy.
Ao Zhang was born in Sichuan, China, in 1969. He received his B.S. degree in Chemistry in 1992 from Sichuan Normal College, now Xihua Normal University. He was awarded the M.S. degree in Organic Chemistry in 1995 from Nankai University. Then, he worked at the Shanghai Institute of Organic Chemistry for 2 years and joined the predoctoral program of the same Institute in 1997 under the supervision of Professor Biao Jiang. After he was awarded the Ph.D. diploma in Organic Chemistry in 2000, he joined Professor Alan P. Kozikowskis Drug Discovery Group at Georgetown University Medical Center as a Postdoctoral Fellow. In 2002, he joined Professor John L. Neumeyers Medicinal Chemistry Program as a Research Investigator at McLean Hospital, Harvard Medical School. He was promoted to Instructor at Harvard Medical School in 2003 and Assistant Director of the Medicinal Chemistry Program at McLean Hospital in 2004. He was awarded Alfred Pope Young Investigator Award in 2004 and Adam Corneel Young Investigator Award in 2005 from Harvard Medical School. In 2006 he received the Hundred Talent Project award from the Chinese Academy of Sciences, and became the Professor of Medicinal Chemistry at Shanghai Institute of Materia Medica (SIMM). In 2011, he was awarded the Distinguished Young Investigator Award from Chinese Natural Science Foundation. His research interests include the design and synthesis of novel small molecules as structural and functional probes for the diagnosis and treatment of brain disorders and cancer by using the state-of-art medicinal chemistry strategy. He has authored or co-authored over 80 publications and 40 patents. Several drug candidates from his research group are now under preclinical studies.
Adnan S Abu-Surrah
Catalysis by Design; Polymer Chemistry; Fabrication of molecularly imprinted polymers (MIP); Electrical properties of polymer nanocomposites; Heterogeneous Catalysis; Medicinal Chemistry; Kinetic and mechanism of oxidation of amino acids via transition metal complexes.
Adnan Salim Abu-Surrah received his B.Sc. in Chemistry in 1985 from Qatar University (Excellent with First-Class Honour), M.Sc. degree in 1989 from Jordan University, Ph.D. with the honour degree (summa cum laude) in 1997 from Ulm University in inorganic chemistry and material science. He has worked as adjunct professor in inorganic chemistry and catalysis at Helsinki University, Chemistry Department (2000) and professor of inorganic and materials chemistry at Hashemite University, Chemistry Department (2014). Currently, he is a full professor of inorganic chemistry at Qatar University, Chemistry Department.He has worked as a visiting professor in University of Helsinki (2002), Ulm University (2003), Al-Al-Bayt University (2007), and Technical University of Munich (2011). Published about 78 peer reviewed papers, 10 reviews, 3 books, 32 international conference proceedings and holds a number of patents (Scopus Author ID: 7003503511; h index 20, National ID: 1525). He is a member of several professional societies, scientific committees, and advisory boards. He was appointed by the Prime minister in the board of Higher Accreditation Commission of Academic Institutions in Jordan (2011-2014) and Committee of Scientific Research Support Fund since 2014, Ministry of Higher Education and Scientific Research, Jordan. He received the DAAD Prize- Germany for Excellence in 1996, the German Industry Prize 1997, the Magnus Ehrnrooth award of Science-Finland 1999, the Hisham Hijjawi Award for Applied Sciences in the field of industry and energy in 2002, the Hashemite University Distinguished Professor Award in 2002, and the SCOPUS (ELSEVIER) award in recognition for contribution to Science", 2009.His research activities include: (i) Design and synthesis of transition metal complexes and their application in homgeneous catalaysis (polymerization and copolymerization of alkenes with polar monomers, hydrogenation, and hydroformylation). The work here also covered the chemical and physical characterization of the isolated materials. (ii) Material design. (iii) Catalytic application of novel polymer supported catalysts. (iv) Kinetic and mechanism of oxidation of amino acids via transition metal complexes. (v) Synthesis and cytotoxic evaluation of antitumor platinum and palladium compounds. (vi) Fabrication of molecularly imprinted polymers (MIP): towards wastewater treatment, chiral separation, and pre-concentration-solid phase extraction. (vii) Re-orient university curricula to address sustainability.
Ali A Ensafi
Isfahan University of Technology
Chemical (Optodes) and Electrochemical Sensors; Microsensors & Nanosensors; Especially Based on DNA and Antigen Interaction; Separation Techniques & Flow Injection Analysis. Introduction of New Modified Voltammetric & Amperometric Sensors Based on Nanoparticles Using DNA and Antibody/Antigen to Construction of Biosensors and Pharmaceutical Sensors; Environmental Trace Analysis.
Islamic Azad University
Synthesis of Organic chemistry; Drugs and Heterocyclic compounds by HPAs catalysts; Nanocatalysts; Green Catalysts; Green; Novel methodology.
Ali Gharib was born in 1974, in Mashhad, IRAN. He gained his B.Sc. in pure chemistry and M.Sc. from Islamic Azad University and graduated with a first class honour degree in Ph.D in Organic chemistry, too. His research interests include of the synthesis of Organic chemistry and Heterocyclic compounds by Heteropolyacids(HPAs) catalysts.
Khaled Rashad Ahmed Abdellatif
Organic Synthesis; Medicinal Chemistry.
Raja Rizwan Hussain
King Saud University
Steel Reinforced Concrete Technology - Materials & Structures; Especially Corrosion.
Bioinorganic chemistry; Development of metal based anti cancer Drugs; Supramolecular Chemistry ; Development of receptors for biologically relevant cation and anions
Mishra has contributed to significant synthesis of Ru(II) and Ru(III) polypyridyl complexes and screened several of them for their anti-HIV and cytotoxic activities anddiscovered some of them possessing substantially higher anti-HIV activity compared tothe standard azidothymidine (AZT). [Bio-org. Med. Chem., 9, 1667, 2001].Hi compounds also showed cytotoxic and anti-HIV activity against ovariancarcinoma and lung-adeno carcinoma and they have been listed in WHO collections.Another class of compounds synthesized by Prof. Mishra showed cytotoxicity speciallyagainst ileothecal carcinoma and found to be many fold potent as compared to AZT(Metal-Based Drugs, 8, 65, 2001; ibid,8, 113, 2001). Other interesting contributions from Prof. Mishra include the serendipitous observationof interaction of some of the metal complexes with calf-Thymus DNA (New J. chem. (Royal Society Journal) 24, 505, 2000) and nitrite/nitrate reductase activity. (Journal of Inorgaic BioChemistry 86, 581, 2001). Further, several of the Ru(ll) complexes synthesized by he facilitated the photoinduced energy/electron transferprocess. These metal complexes thus have potential as molecular electronic materials(Chemistry Letters 447, 1997, Transition Met. Chem. 25, 579, 2000 and Bull. Chem.Soc. Japan. 73, 2051, 2000). He has developed new Co(III) complexes which bind to thymine and adenine bases and provided structurally interesting materials. (Bull. Mater. Sci,24, 339,2001). More recently, Re(II) complexes have been observed to show physiological acceptability, as tested in mice and they have been found to bind to LDH. Some of the complexes showed increase in P53 level and induced release of cytochrome c and DNA cleavage. He also developed simple nano-size sheet-like and tubular materials and metallo supramolecules, which have potential to act as a receptor for binding of phenol and hexa fluorobenzene. He has widely travelled to Japan , Germany, USA, Belgium, China ,Taiwan, and Spain and many other places and has psented his lectures in several International conferences including 100th Nobel award anniversary to Paul ehrlich” Magic Bullet” conference organized in Nuremberg, Germany during Oct 2-5, 2008. On National level, he has been awarded by indian chemical society ,Kolkata and CRSI, Bangalore. He is in Executive council of IBS and CRSI. He has supervised many Ph.D. students and Post-doctoral Fellows. Professor Mishra has co-authored six book Chapters ( C.V). He was a Fellow of Royal Society in London. .
Maya Shankar Singh
Banaras Hindu University
Cleavage & formation of C-C, C-O, C-N, and C-S bonds via pot/atom/step/cost economic way; Design and development of sustainable diversity oriented synthetic (DOS) methods for biologically important molecules and drug intermediates.
Maya Shankar Singh is Professor in Organic Chemistry at Institute of Science, Banaras Hindu University, Varanasi, INDIA. During his sabbatical, he visited University of Arizona, Tucson, USA; Nagoya Institute of Technology, Nagoya, Japan; Loughborough University, UK, University of Leicester, UK and RWTH Aachen University, Aachen, Germany. His research interests are centered on Synthetic Organic Chemistry with special emphasis toward the development of novel building block precursors, new eco-compatible synthetic methods, multicomponent domino/tandem reactions, and structural studies. The main focus of his researchis to develop highly selective one-pot multicomponent domino reactions (MDRs) for numerous useful scaffolds with substituent and skeletal diversity. By virtue of astonishing success of newly developed domino reactions with regard to atom/step/cost-economy, sustainability, versatility, scope, and applicability,they have received significant attention of synthetic, medicinal, and material chemists. Extraordinarily, the remarkable renovation of a simple molecule-oxo/-enolic dithioester has been achieved towards its diversification for variety of purposes exhibiting power and diversity of domino/cascade annulations. An effective control for the selective cleavage and formation of carbon-carbon and carbon-heteroatom (C-N, C-O & C-S) bonds in one-pot in a single operation have been achieved.He has successfully guided 20 Ph. D. students, which resulted over 150 publications and 8 reviews in peer reviewed journals. Additionally, Prof. Singh has also authored three textbooks in organic chemistry published from Pearson-Education and Wiley-VCH, Weinheim, Germany. His some notablerecognitionsinclude CRSI Bronze Medal-2017; UGC-BSR One-Time-Grant (2015); Member, American Chemical Society (2015-2018); Vice-Chancellor’s (BHU) award for Excellence in Research (2014); Fellow of the Indian Academy of Sciences, India (FNASc) (2013).
Sant Baba Bhag Singh University
Development of new organic synthetic methodologies; Synthesis of novel six member Nitrogen and Oxygen based heterocyclic compounds; Synthesis of bioactive annulated pyrimidine derivativies using sonochemistry; Microwave techniques; Catalytic activity of different nitrogen based organo catalysts (DABCO, DBU, DBA, DAMP etc) for the synthesis of fused Pyrano/Pyridopyrimidine/uracil derivativies; Domino Knoevenagel–condensation-Michael addition pathways for synthesis of heterocyclic compounds.
Ajmal Rashid Bhat received his master of Science (M.Sc.) in Chemistry from Department of Chemistry, Jiwaji University Gwalior (India) in 2007 and master of philosophy (M.phil) in Chemistry from Department of Chemistry Vikram University, Ujjain (India) in 2011.He has completed his Ph.D. degree from Department of Chemistry, R.T.M. Nagpur University, Nagpur, Maharashtra (India) in 2016. He is currently working as Assistant Professor (Chemistry), Department of Chemistry and also Assistant director research and development at Sant Baba Bag Sing University- Jalandhar Punjab-144030 (India). He is presently engaged both in academics and research. He has more than twenty international research papers in different reputed journals and also more than ten international conferences. He has been awarded at different international conferences. He is reviewer of different journals like Journal of Material and Environmental Science, Journal of sudia chemical society (Elisvier), Ultrasonics Sonochemistry (Elisvier), Journal of Chitin and Chitosan, Journal of Catalysis for Sustainable Energy, American Journal of PharmTech Research, International Journal of pharma and Bio Science and Letters in Drug Design and Discovery
A Venkat Narsaiah
Indian Institute of Chemical Technology
CalAsia Pharmaceuticals Inc
Structural biology; Drug discovery; X-ray crystallography; Molecular Biology.
Prasad is the co-founder and Vice President of Research of CalAsia Pharmaceuticals. He has been the core member of drug discovery teams that discovered multiple drug candidates, currently at various stages of preclinical and clinical development, including MK-4965, a second generation HIV-1 AIDS drug candidate discovered at Merck. He was the lead crystallographer and core member of the team that discovered NESINA, Syrrx and Takeda San Diego\s DPP-IV inhibitor, a FDA approved drug to treat type II diabetes and first drug to be discovered using structure-based methods at Syrrx. He designed, built and implemented fragment based crystallography screening technology platforms at Syrrx (Takeda), Merck and Metabasis. He is the recipient of Merck Research Laboratory meritorious researcher award consecutively for 2004 and 2005. He has co-authored over 45 peer reviewed research articles, holds six US and international patents. He serves on the editorial board of Current Protein and Peptide Science.He obtained his Ph.D., from Indian Institute of Science, Bangalore, India and post-doctoral training at University of Minnesota Medical School and the Scripps Research Institute, La Jolla, California, where he subsequently grew to the ranks of Assistant Professor.
University of Pennsylvania
Shanghai Institute of Organic Chemistry
University of Kragujevac